Di Wu

机构：Nanjing Agricultural University, Army Medical University, Dalian Medical University, Nantong University, Affiliated Hospital of Nantong University, Daping Hospital, Second Affiliated Hospital of Chongqing Medical University, Xinqiao Hospital, Shanghai East Hospital, Ministry of Education, Chongqing Medical University · ORCID：0000-0002-6064-9990

发表论文 44 篇 · 总被引 598 次 · h-index 15

代表论文

CPT1A‐IL‐10‐mediated macrophage metabolic and phenotypic alterations ameliorate acute lung injury (2024 · Clinical and Translational Medicine · 被引 47)
Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasis (2025 · Developmental Cell · 被引 41)
An mTOR siRNA‐Loaded Spermidine/DNA Tetrahedron Nanoplatform with a Synergistic Anti‐Inflammatory Effect on Acute Lung Injury (2022 · Advanced Healthcare Materials · 被引 40)
Metformin Combining PD-1 Inhibitor Enhanced Anti-Tumor Efficacy in STK11 Mutant Lung Cancer Through AXIN-1-Dependent Inhibition of STING Ubiquitination (2022 · Frontiers in Molecular Biosciences · 被引 25)
Extracellular HMGB1 Impairs Macrophage-Mediated Efferocytosis by Suppressing the Rab43-Controlled Cell Surface Transport of CD91 (2022 · Frontiers in Immunology · 被引 24)
Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer (2024 · Acta Pharmacologica Sinica · 被引 23)